The Quest for Stem Cells: Discovering Where They Come From
This short video explains that stem cells are special cells that can develop into different types of cells, and are found in all organisms, including plants, animals, and humans. Human stem cells can come from infant stem cells or adult stem cells. Embryonic stem cells come from blastocysts, which are formed about 5-6 days after […]
Introduction to the Types of Stem Cell Therapies
Stem cell therapies are an emerging field of medical treatments that have the potential to revolutionize the way we treat a variety of medical conditions. From orthopedic injuries and degenerative diseases to cancer and immune disorders, stem cell therapies offer hope and healing to many who otherwise have not found successful solutions. Let’s take a […]
Exploring the Benefits of MSCT for IHD
Introduction Mesenchymal Stem Cell Therapy (MSCT) is a promising, yet still experimental form of treatment that has the potential to revolutionize the management of Ischemic Heart Disease (IHD). What are Mesenchymal Stem Cells Mesenchymal stem cells (MSCs) are a type of adult stem cell found in the body that can differentiate into several different types […]
The Different Types of Stem Cells and How They are Used in Therapy
If you’re dealing with a health condition and looking for ways to get relief, you may have heard of stem cell therapy. But what are stem cells, and how can they help? Let’s take a look at the different types of stem cells and how they can be used in therapy. Mesenchymal Stem Cells (MSCs) […]
I Am ALS and Veterans with ALS send an Open Letter to FDA Requesting an Advisory Committee Meeting to Discuss NurOwn
WASHINGTON, Nov. 23, 2022 /PRNewswire/ — To the Honorable Dr. Robert Califf and Dr. Peter Marks: We represent Veterans with ALS who support Brainstorm Cell Therapeutics’ request for the FDA to hold a public Advisory Committee meeting (“AdCom”) to engage in scientific discourse about the “clinically meaningful” evidence supporting FDA’s approval of a mesenchymal stem cell therapy, NurOwn. When we […]
Clinical Evidence on Stem Cell Therapy – Dr. Joy Kong
Recording of Dr Joy Kong speaking at the 9th Annual International Cell Surgical Conference about the clinical evidence that currently exists in stem cell treatments.
Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027
New York, Oct. 19, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Mesenchymal Stem Cells (MSC) Industry” – https://www.reportlinker.com/p05961465/?utm_source=GNWOnline interactive peer-to-peer collaborative bespoke updatesAccess to our digital archives and MarketGlass Research PlatformComplimentary updates for one year Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027 Amid the COVID-19 crisis, […]
ANDREWS MEDICINE AND CELLTEX THERAPEUTICS CORPORATION JOIN FORCES TO BRING CUTTING EDGE TECHNOLOGIES TO ATHLETIC INJURIES
HOUSTON, Oct. 4, 2022 /PRNewswire/ — James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the […]
The Evolution of Stem Cell Therapy in the United States
Dr. Josh Crose summarizes the development and evolution of Stem Cell Therapy and the advent of Mesenchymal Stem Cell Extracellular Vesicles (Exosomes). Video Transcript: Hi, this is Dr Joshua Crose with Capitis Medical and Aesthetics. I’d like to talk about stem cell therapies and provide you a little bit of a background in summary about […]
Global Mesenchymal Stem Cells Market Intelligence Report 2022: Industry to reach $5.84 Billion by 2027
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) — The “Mesenchymal Stem Cells Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Mesenchymal Stem Cells Market is projected to reach USD 5,847.88 million by 2027 from USD 2,731.51 million in 2021, at a CAGR 13.52% during the forecast period. […]